Lenalidomide Market Prospects and Growth Assessment Presented Until the End of 2026
Lenalidomide is an equivalent to thalidomide, developed to reduce dose-limiting side effects of thalidomide such as constipation, sedation, neuropathy, and thromboembolism. Lenalidomide is used to manage anemia in individuals who have a certain form of myelodysplastic syndrome. Lenalidomide and low-dose of dexamethasone are used to treat patients with multiple myeloma. It is also utilized to treat the mantle cell lymphoma patients. Lenalidomide is primarily used for the treatment for multiple myeloma. The treatment for multiple myeloma has changed considerably in...
View full press release